Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter

European Journal of Nuclear Medicine

Volumn 29, Issue 7, 2002, Pages 842-854

  Petrich, T ^a   Helmeke, H J ^a   Meyer, G J ^a   Knapp, W H ^a   Pötter, Eyck ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Astatine; Cancer; Gene therapy; Radioiodine; Sodium iodide symporter

Indexed keywords

ASTATINE 211; PERTECHNETIC ACID TC 99M; SODIUM IODIDE I 123; SODIUM IODIDE I 125; SODIUM IODIDE SYMPORTER; SODIUM ION; SODIUM PERCHLORATE; ASTATINE; COTRANSPORTER; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; TUMOR MARKER;

ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOSIMETRY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG UPTAKE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; RADIATION ABSORPTION; RADIOACTIVITY; STEADY STATE; THYROID CELL; TUMOR SCINTISCANNING; XENOTRANSPLANTATION; ADENOCARCINOMA; ANIMAL; CANCER TRANSPLANTATION; CELL CULTURE; COLON TUMOR; COMPARATIVE STUDY; GENE EXPRESSION; GENETICS; GLIOBLASTOMA; METABOLISM; REFERENCE VALUE; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; THYROID TUMOR; TISSUE DISTRIBUTION;

ADENOCARCINOMA; ADENOCARCINOMA, PAPILLARY; ANIMAL; ASTATINE; COLONIC NEOPLASMS; COMPARATIVE STUDY; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; IODINE RADIOISOTOPES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SODIUM PERTECHNETATE TC 99M; SYMPORTERS; THYROID NEOPLASMS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; ANIMALS; HUMANS;

EID: 0036090071     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0784-7     Document Type: Article

References (57)

1. Radioiodine and other treatment and outcomes
2. Cloning and characterization of the thyroid iodide transporter
3. Cloning of the human sodium iodide symporter
4. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter
5. Cloning of the mouse sodium iodide symporter and its expression in the mammary gland and other tissues
6. Iodide transport in the thyroid gland
7. Molecular analysis of the sodium/iodide symporter: Impact on thyroid and extrathyroid pathophysiology
8. Analysis of human sodium iodide symporter gene expression in extra-thyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa
9. - symporter distribution in human extra-thyroidal tissues
10. The mammary gland iodide transporter is expressed during lactation and in breast cancer
11. Expression of the sodium iodide symporter in human kidney
12. Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: Side-effects and influence of age
13. - symporter distribution in human thyroid tissues: An immunohistochemical study
14. Iodide symporter gene expression in human thyroid tumors
15. Sodium/iodide symporter: A key transport system in thyroid cancer cell metabolism
16. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer
17. 131I uptake in recurrent lesions of differentiated thyroid carcinoma
18. Rapid communication: Predominant intracellular overexpression of the Na(+)/I(-) symporter (NIS) in a large sampling of thyroid cancer cases
19. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells
20. Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas
21. Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells
22. - symporter gene methylation status
23. Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells
24. Innovative strategies for the treatment of thyroid cancer
25. - symporters
26. - symporter gene
27. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene
28. - symporters for radioiodide concentrator gene therapy
29. - symporter in human glioma cells by adenovirus-mediated gene delivery
30. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines
31. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter
32. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy
33. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line
34. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: Effect on clonogenicity in both two-and three-dimensional models
35. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells
36. Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters
37. Artificially radioactive element 85
38. Toxicity of astatine-211 in the mouse
39. 131I as labels of a monoclonal antibody and F(ab')2 fragment
40. 125I transport in porcine thyroid epithelial cells cultured in bicameral chambers
41. Development of monoclonal antibodies against the human sodium iodide symporter: Immunohistochemical characterization of this protein in thyroid cells
42. Iodide transport in a continuous line of cultured cells from rat thyroid
43. Dosimetrie inkorporierter strahler
44. - symporter. Mechanism, stoichiometry, and specificity
45. Targeted therapy using alpha emitters
46. Astatine-211-labeled radiotherapeutics: An emerging approach to targeted alpha-particle radiotherapy
47. Radioimmunotherapy with alpha-emitting nuclides
48. Recent advances in the organic chemistry of astatine
49. - symporter. Mechanism, stoichiometry, and specificity
50. - symporter
51. Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells
52. Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumors
53. Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers
54. Establishment of two thyroid carcinoma cell lines (8305C, 8505C) bearing p53 mutations
55. Classification of human colorectal adenocarcinoma cell lines
56. Absence of HeLa cell contamination in 169 cell lines derived from human tumors
57. Characterization of a continuous human glioma cell line DBTRG-05MG: Growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses